While SEV-treated DM mice showed a trend toward greater neuronal loss (mean: 0.409 vs. 0.622).
← all excerpts
Multi-omics analysis reveals sevoflurane exacerbates cognitive impairment in diabetic mice by disrupting lipid metabolism.
1
—
—
While SEV-treated DM mice showed a trend toward greater neuronal loss (mean: 0.409 vs. 0.622).